Abstract
To compare renal functional outcomes in patients with and without chronic kidney disease (CKD) to identify predictors of change in renal function after percutaneous nephrolithotomy (PCNL). We reviewed patients who underwent PCNL by a single surgeon over 3.5 years. Patients’ pre- and post-operative Glomerular Filtration Rate (GFR) was calculated. Baseline GFR < 60 ml/min/1.73 m2 (stage ≥ 3 CKD) defined our CKD cohort. Patients’ baseline renal function, comorbidities, stone parameters, and intra-operative variables were analyzed to determine the relationship with post-operative renal function after PCNL by multivariate analysis. 202 patients were analyzed. Mean follow-up time was 16 months. At baseline, 163 (80.7%) patients were free of CKD and 39 (19.3%) had CKD. Patients without CKD had an overall decrease in GFR from 105.6 to 103.3 ml/min/1.73 m2 (p = 0.494). 14/163 (8.6%) non-CKD patients experienced a significant decline in renal function after PCNL; 7/163 (4.3%) developed de novo CKD and 7 had a ≥ 30% decline in GFR. Patients with CKD had an overall increase in mean GFR post-operatively, from 47.3 to 54.0 ml/min/m2 (p = 0.067). Two in this cohort (5.1%) experienced a > 30% decline in renal function post-operatively. Age, gender, African American race, presence of comorbidities and pre-operative CKD were not significant predictors of renal function post-operatively on multivariate analysis. PCNL in this cohort appears GFR neutral in the setting of baseline CKD. CKD was not predictive of renal functional decline after PCNL. Given that stone disease carries a high recurrence rate and that CKD is associated with stone formers, further investigation into predictors of renal function change after PCNL is warranted.
Similar content being viewed by others
References
Litwin M, Saigal C (2012) Economic impact of urologic disease, N.I.o.H. National Institute of Diabetes and Digestive and Kidney Diseases, US Department of Health and Human Services, Editor. 2012: Urologic Diseases in America. NIH Publication 12-7865, Washington, DC, p 486
Alexander RT et al (2012) Kidney stones and kidney function loss: a cohort study. BMJ 345:e5287
Ferraro PM et al (2013) History of kidney stones and the risk of coronary heart disease. JAMA 310(4):408–415
Melton LJ III et al (1998) Fracture risk among patients with urolithiasis: a population-based cohort study. Kidney Int 53(2):459–464
Edvardsson VO et al (2013) Temporal trends in the incidence of kidney stone disease. Kidney Int 83(1):146–152
Akman T et al (2012) The impact of metabolic syndrome on long-term outcomes of percutaneous nephrolithotomy (PCNL). BJU Int 110(11 Pt C):E1079–E1083
Bilen CY et al (2008) Impact of percutaneous nephrolithotomy on estimated glomerular filtration rate in patients with chronic kidney disease. J Endourol 22(5):895–900
Shoag J et al (2014) Risk of chronic and end stage kidney disease in patients with nephrolithiasis. J Urol 192(5):1440–1445
El-Zoghby ZM et al (2012) Urolithiasis and the risk of ESRD. Clin J Am Soc Nephrol 7(9):1409–1415
Rule AD et al (2009) Kidney stones and the risk for chronic kidney disease. Clin J Am Soc Nephrol 4(4):804–811
Kurien A et al (2009) The impact of percutaneous nephrolithotomy in patients with chronic kidney disease. J Endourol 23(9):1403–1407
Preminger GA, Lingerman JE, Nakada SY, Pearle MS, Wolf JS (2009) Report on the management of staghorn calculi (2005). Clinical guidelines 2005. https://www.auanet.org/education/guidelines/staghorn-calculi.cfm. Accessed 2015
Ozden E et al (2012) Long-term outcomes of percutaneous nephrolithotomy in patients with chronic kidney disease: a single-center experience. Urology 79(5):990–994
Kuzgunbay B et al (2010) Long-term renal function and stone recurrence after percutaneous nephrolithotomy in patients with renal insufficiency. J Endourol 24(2):305–308
Stevens LA, Viswanathan G, Weiner DE (2010) Chronic kidney disease and end-stage renal disease in the elderly population: current prevalence, future projections, and clinical significance. Adv Chronic Kidney Dis 17(4):293–301
Ordon M et al (2015) A population based study of the changing demographics of patients undergoing definitive treatment for kidney stone disease. J Urol 193(3):869–874
Eknoyan G (2003) Meeting the challenges of the new K/DOQI guidelines. Am J Kidney Dis 41(5 Suppl):3–10
Levey AS, Coresh J (2012) Chronic kidney disease. Lancet 379(9811):165–180
Drew DA et al (2017) Association between soluble Klotho and change in kidney function: the health aging and body composition study. J Am Soc Nephrol 28(6):1859–1866
Go AS et al (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351(13):1296–1305
Sigurjonsdottir VK et al (2015) Impact of nephrolithiasis on kidney function. BMC Nephrol 16:149
Sairam K et al (2012) Percutaneous nephrolithotomy and chronic kidney disease: results from the CROES PCNL global study. J Urol 188(4):1195–1200
Collins AJ et al (2011) US renal data system 2010 annual data report. Am J Kidney Dis 57(1 Suppl 1):A8 (e1–526)
Wuerzner G et al (2010) Marked association between obesity and glomerular hyperfiltration: a cross-sectional study in an African population. Am J Kidney Dis 56(2):303–312
Hsu CY et al (2009) Risk factors for end-stage renal disease: 25-year follow-up. Arch Intern Med 169(4):342–350
Rosenberg M, Hsu CY (2004) Chronic kidney disease and progression. NephSAP 3(6):304–308
Derose SF et al (2013) Racial differences in estimated GFR decline, ESRD, and mortality in an integrated health system. Am J Kidney Dis 62(2):236–244
Nouralizadeh A, Sichani MM, Kashi AH (2011) Impacts of percutaneous nephrolithotomy on the estimated glomerular filtration rate during the first few days after surgery. Urol Res 39(2):129–133
Handa RK et al (2010) Time-course for recovery of renal function after unilateral (single-tract) percutaneous access in the pig. J Endourol 24(2):283–288
Perez-Fentes D et al (2014) Does percutaneous nephrolithotomy and its outcomes have an impact on renal function? Quantitative analysis using SPECT-CT DMSA. Urolithiasis 42(5):461–7
Handa RK et al (2015) Percutaneous renal access: surgical factors involved in the reduction of renal function. J Endourol 30(2):178–183
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Watts, K.L., Srivastava, A., Lin, W. et al. Baseline chronic kidney disease does not predict long-term renal functional decline after percutaneous nephrolithotomy. Urolithiasis 47, 449–453 (2019). https://doi.org/10.1007/s00240-019-01113-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00240-019-01113-5